ARID1A and breast cancer: Compared with common luminal breast cancers, NECB has a unique repertoire of somatic mutations, has lower TP53 and PIK3CA mutation occurrence, and is enriched with FOXA1, TBX3 mutations, is similar to neuroendocrine neoplasms from other tissues or organs about ARID1A mutations.